Subscribe to our newsletter.
Copyright 2024 © All rights Reserved Goffin Molecular Technologies
Selected genes and mutations play a crucial role in diagnosis and treatment across various cancers, including breast, colorectal, melanoma, lung, prostate, and others.
The 5 Gene Multiplex 0.1% AF cfDNA product serves as a positive standard for liquid biopsy assays in diagnostic labs and R&D settings. It is also designed for validating and developing diagnostic kits targeting AKT1, BRAF, KRAS, ERBB2, or PIK3CA. This product is made from highly characterized human cfDNA derived from cell lines, ensuring accuracy and reliability in testing.
The selected genes and mutations are critical for both diagnosis and treatment, influencing various types of tumors, including:
– Breast cancer
– Colorectal cancer
– Melanoma
– Non-Small Cell Lung Cancer
– Small Cell Lung Cancer
– Prostate cancer
– Lymphoma
– Head and Neck Cancer
– Hepatocellular Carcinoma
– Multiple Myeloma
– Pancreatic Adenocarcinoma
– Ovarian Cancer
– Bladder Cancer
– Bile Duct Cancer
The 5-Gene-Multiplex 0.1% AF cfDNA product serves as a positive standard for liquid biopsy assays in diagnostic laboratories or R&D settings. It is also useful for the validation and development of diagnostic kits targeting AKT1, BRAF, KRAS, ERBB2, or PIK3CA. This product is derived from highly characterized human cfDNA sourced from cell lines, ensuring reliability and accuracy in your testing processes.
We recommend the use of our human DNA-free plasma products to produce complete workflow controls with this product. Blend the cfDNA as necessary with the DNA depleted plasma to receive plasma materials with the necessary DNA concentrations.
Subscribe to our newsletter.